Again, BMMSC-EVs containing miR-23b promoted dormancy in metastatic breast cancer cells by targeting MARCKS (Myristoylated alanine-rich C-kinase substrate) (Ono et al., 2014). This evidence concerns the gene MARCKS and breast carcinoma.